1982: BSc (Hons), 2:1. Physiology, University of London, UK. 1985: MBBS, St. Bartholomew's Medical School, University of London, UK. 1988: Diploma of Ophthalmology, Royal College of Surgeons, London, UK. 1989: FRCS, Royal College of Surgeons and Physicians, Glasgow, UK. 1990: FRCOphth, Royal College of Ophthalmologists, London, UK. 1994: MD (Res), Molecular Genetics, University of London, UK. 2009: PhD, Cell Biology, University of London, UK. 2009: DIC, Imperial College London. UK. 2011: FRCSC, Royal College of Physicians and Surgeons of Canada.
Kevin Gregory-Evans is currently Professor of Ophthalmology in the Faculty of Medicine, University of British Columbia, and holder of the Julia Levy BC Leadership Chair in Macular Research, Vancouver, Canada. Before 2009 he was Reader in Molecular Ophthalmology, Imperial College London, UK. He underwent clinical ophthalmology training at Moorfields Eye Hospital, London, UK and basic science research training with Professors Alan Bird and Shomi Bhattacharya (Institute of Ophthalmology, London, UK) and Professor Richard Weleber (Oregon Health Sciences University, Portland, Oregon, USA). In 1985 he achieved an MBBS, at St. Bartholomew's Medical School, University of London; in 1994 was awarded an MD in molecular biology, University of London; and in 2009 was awarded a PhD in cell biology, University of London, UK. Dr Gregory-Evans has published 75 peer-reviewed original research articles, 16 research review articles, and 9 book chapters. In 2008 he was elected to the Macular Disease Advisory Group at the Royal College of Ophthalmologists, UK, to advise on setting up retinal disease treatment clinics throughout the UK. Currently, he is Chairman of the Research Infrastructure Working Group and Council Member of the Vancouver Coastal Health Research Institute. He is also an active panel member of the 'BC Stem Cell and Regenerative Medicine Steering Group', the 'Canadian Institutes of Health Research' and the 'California Institute of Regenerative Medicine Panel, California, USA'. He is an active speaker for lay audiences including: the 'Canadian National Institute for the Blind'; the 'British Retinitis Pigmentosa Society'; and the 'Royal National Institute for the Blind (UK)'. Most recently he was elected as a Director of the Foundation Fighting Blindness Canada.
His research interests include novel approaches in the diagnosis and treatment of retinal disease. 1. CIHR Team Grant ($1.5 million): Novel molecular approaches in the treatment of retinal disease. 2. Sharon Stewart Research Award($1.47 million): Cell-based therapies for aniridia. 3. UBC Department of Ophthalmology ($0.5 million): Stem cell therapies for retinal disease.
- Cell transplantation - 2012, Nov 27
- Human molecular genetics - 2012, Apr 25
- Ophthalmic research - 2011, Dec 14
- Current biology : CB - 2007, Dec 19
- Human molecular genetics - 2007, Oct 1